Shimadzu, a leading global supplier of analytical measurement and testing equipment, has recently released the Nexera IC ion ...
Ahead of its official release later this spring, today Rivan is announcing full pricing and trim levels for its long-awaited R2 electric SUV. The rollout for the company's first mid-size (two-row) ...
Rivian's upcoming R2 SUV is positioned as a more affordable electric vehicle from the company, starting around $45,000. The Tesla Model Y is the current electric SUV sales leader and starts at a ...
Rivian (RIVN) holds its full R2 reveal on March 12, 2026. First customer deliveries of the mid-size SUV target Q2 2026. Rivian achieved its first full year of positive gross profit at $144M in 2025.
A key component in lowering the price point is rationalizing the number of production variants. Transitioning from the R1’s body-on-skateboard architecture to the R2’s unitized construction with the ...
After graduating with an MBA, Jared pursued his love of cars by becoming an automotive journalist. An internship with CarBuzz grew into his current position as Editor At Large. Jared now flies around ...
Rivian on Thursday announced the final specs and pricing for its R2 lineup, providing the clearest picture yet of its most important vehicle ever. Rivian needs the R2 to be a hit to scale up its ...
It might feel like a tired cliche to call a new electric car a Tesla rival. But Rivian is a company that shares more with Tesla than two motors and a skateboard chassis. Like Tesla, Rivian is a ...
Idaho State University is building on its partnership with an Idaho- based private medical school. Idaho State and the Idaho College of Osteopathic Medicine are poised to sign another joint agreement.
Using the ISA/IEC 62443 Standards to Secure Your Industrial Control Systems (IC32) provides a detailed look at how the ISA/IEC 62443 standards framework can be used to protect critical control systems ...
Abstract: Continuous monitoring of fluid status through bioimpedance (Bio-Z) measurement of thoracic magnitude or phase is critical in reducing the mortality of chronic heart failure (CHF) patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results